| Value | ₹0.48 Cr |
|---|
BSE filing, NSE: MAXIND. Summary written from the filing by ALFA Finder's alert engine.
Max India Ltd: key numbers
- Share price
- ₹149.90
- Market cap
- ₹844.2 Cr
- Revenue (annual)
- ₹190.6 Cr
- Net profit (annual)
- ₹-121.8 Cr
- P/E (TTM)
- -6.4×Sector 21.4×
- Promoter holding
- 48.22%-1.55% QoQ
- FII holding
- 6.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max India Ltd
All →Max India Other Announcement
Max India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory reporting requirements.
Max India Debt & Borrowing: ₹40 Cr
Max India executed a Letter of Comfort for Rs. 40 Crores in favor of Aditya Birla Capital Limited, supporting a credit facility for its subsidiary, Antara Senior Living.
- Value
- ₹40.00 Cr
Max India Partnership
Max India Foundation partnered with ISB to launch SCALE, a senior-care research initiative. Antara Senior Care joined as founding industry partner to advance evidence-based care.
Max India Annual General Meeting
Max India Limited concluded its 7th Annual General Meeting on August 19, 2026. Shareholders considered the adoption of FY26 financial statements and the re-appointment of Mr. Rajit Mehta.
Max India Earnings Call Transcript: Key Takeaways
Max India delivered a 66% YoY revenue jump to ₹68.6 Cr, yet remains loss-making with a ₹25 Cr EBITDA deficit, masked by optimistic real estate execution narratives.
- Call
- Guides 100% growth
Max India Investor Presentation: Key Takeaways
Max India (Antara) reported Q1FY27 consolidated revenue of Rs 68.6 Cr, up 66% YoY. Strategy focuses on expanding senior living residences, assisted care services, and the AGEasy product portfolio.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.